• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biomed Res Int . An Interpretable Model-Based Prediction of Severity and Crucial Factors in Patients with COVID-19

tetano

Editor, Senior Moderator
Biomed Res Int


. 2021 Mar 1;2021:8840835.
doi: 10.1155/2021/8840835. eCollection 2021.
An Interpretable Model-Based Prediction of Severity and Crucial Factors in Patients with COVID-19


Bowen Zheng[SUP] 1 [/SUP], Yong Cai[SUP] 2 [/SUP], Fengxia Zeng[SUP] 1 [/SUP], Min Lin[SUP] 3 [/SUP], Jun Zheng[SUP] 3 [/SUP], Weiguo Chen[SUP] 1 [/SUP], Genggeng Qin[SUP] 1 [/SUP], Yi Guo[SUP] 4 [/SUP]



Affiliations

Abstract

This study established an interpretable machine learning model to predict the severity of coronavirus disease 2019 (COVID-19) and output the most crucial deterioration factors. Clinical information, laboratory tests, and chest computed tomography (CT) scans at admission were collected. Two experienced radiologists reviewed the scans for the patterns, distribution, and CT scores of lung abnormalities. Six machine learning models were established to predict the severity of COVID-19. After parameter tuning and performance comparison, the optimal model was explained using Shapley Additive explanations to output the crucial factors. This study enrolled and classified 198 patients into mild (n = 162; 46.93 ? 14.49 years old) and severe (n = 36; 60.97 ? 15.91 years old) groups. The severe group had a higher temperature (37.42 ? 0.99?C vs. 36.75 ? 0.66?C), CT score at admission, neutrophil count, and neutrophil-to-lymphocyte ratio than the mild group. The XGBoost model ranked first among all models, with an AUC, sensitivity, and specificity of 0.924, 90.91%, and 97.96%, respectively. The early stage of chest CT, total CT score of the percentage of lung involvement, and age were the top three contributors to the prediction of the deterioration of XGBoost. A higher total score on chest CT had a more significant impact on the prediction. In conclusion, the XGBoost model to predict the severity of COVID-19 achieved excellent performance and output the essential factors in the deterioration process, which may help with early clinical intervention, improve prognosis, and reduce mortality.
 
Back
Top Bottom